Eam Investors, LLC Assembly Biosciences, Inc. Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 03, 2018	SELL	$39.21 - $50.29 $1.27 Million - $1.63 Million	-32,338 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$41.7 - $64.16 $217,131 - $334,081	-5,207 Reduced 13.87%	32,338 $1.59 Million
Q4 2017 May 21, 2018	SELL	$28.58 - $49.91 $772,574 - $1.35 Million	-27,032 Reduced 41.86%	37,545 $1.7 Million
Q4 2017 Feb 12, 2018	BUY	$28.58 - $49.91 $1.46 Million - $2.55 Million	51,015 Added 376.16%	64,577 $2.92 Million
Q3 2017 Nov 08, 2017	BUY	$23.08 - $34.92 $313,010 - $473,585	13,562	13,562 $474,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $717M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.